Cite
Afonin KA, Dobrovolskaia MA, Ke W, et al. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation. Adv Drug Deliv Rev. 2021;181:114081doi: 10.1016/j.addr.2021.114081.
Afonin, K. A., Dobrovolskaia, M. A., Ke, W., Grodzinski, P., & Bathe, M. (2021). Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation. Advanced drug delivery reviews, 181114081. https://doi.org/10.1016/j.addr.2021.114081
Afonin, Kirill A, et al. "Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation." Advanced drug delivery reviews vol. 181 (2021): 114081. doi: https://doi.org/10.1016/j.addr.2021.114081
Afonin KA, Dobrovolskaia MA, Ke W, Grodzinski P, Bathe M. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation. Adv Drug Deliv Rev. 2021 Dec 13;181:114081. doi: 10.1016/j.addr.2021.114081. Epub 2021 Dec 13. PMID: 34915069.
Copy
Download .nbib